All In MedTech

Device Trial Radar · NCT06513390

Development of an Exoskeleton for Patients' Mobility.

The Development of an Exoskeleton System for Assisting and Enhancing Patients' Mobility.

Last checked: Nov 20, 2026Latest source record: Jul 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

8

Actual

Start

Jul 1, 2022

Primary completion

Jul 12, 2022

Study completion Jul 12, 2022

Sponsor

Lead sponsor
Vidyasirimedhi Institute of Science & Technology (VISTEC)Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 22, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to investigate the performance of a state-of-the-art adaptive CPG-based exoskeleton control system (intelligent mode) under a multi-metric analysis (involving three-dimensional gait analysis, muscle activity, oxygen consumption, user comfort, and exoskeleton performance scores) and comparing it to a standard commercial exoskeleton control system (default mode) The main question it aims to answer is: Could the adaptive version improve natural walking and essential lower limb motions? Participants will: All participants were assigned into two groups to receive an alternate sequence of walking with the intelligent mode or the default mode of the lower-limb exoskeleton Exo-H3 at high and normal speed.

Conditions

  • Healthy

Interventions

  • Exoskeleton of default modeDevice

    Default mode: A standard control system offering a conventional assistive function of Exo-H3.

  • Exoskeleton of Intelligent modeDevice

    Intelligent mode: The adaptive CPG-based control system developed by our researchers from Exo-H3.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. gait kinematic of pelvic hip, knee and ankle joint.Time frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Faculty of Medicine Ramathibodi Hospital, Mahidol University

    Bangkok, Thailand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.